| Ethical issues of CRISPR technology and gene editing through the lens of solidarity JJ Mulvihill, B Capps, Y Joly, T Lysaght, HAE Zwart, R Chadwick, ... British medical bulletin 122 (1), 17-29, 2017 | 99* | 2017 |
| Informed consent for human genetic and genomic studies: a systematic review A Khan, BJ Capps, MY Sum, CN Kuswanto, K Sim Clinical genetics 86 (3), 199-206, 2014 | 43 | 2014 |
| Addiction Neurology: Ethical and Social Implications (EMCDDA Monographs; Number 9) W Carter, A., Capps, B., Hall Official Publications of the European Communities, 2009 | 42* | 2009 |
| Ethical and Regulatory Challenges with Autologous Adult Stem Cells: A Comparative Review of International Regulations T Lysaght, I Kerridge, D Sipp, G Porter, BJ Capps Asia Research Institute, National University of Singapore, 2015 | 35 | 2015 |
| Justice Is the Missing Link in One Health: Results of a Mixed Methods Study in an Urban City State T Lysaght, B Capps, M Bailey, D Bickford, R Coker, Z Lederman, ... PloS one 12 (1), e0170967, 2017 | 32 | 2017 |
| One Health, Vaccines and Ebola: The Opportunities for Shared Benefits B Capps, Z Lederman Journal of Agricultural and Environmental Ethics, 1-22, 2015 | 32 | 2015 |
| One Health and paradigms of public biobanking B Capps, Z Lederman Journal of medical ethics 41 (3), 258-262, 2015 | 30 | 2015 |
| Oversight for Clinical Uses of Autologous Adult Stem Cells: Lessons from International Regulations T Lysaght, I Kerridge, D Sipp, G Porter, BJ Capps Cell Stem Cell 13 (6), 647-651, 2013 | 30 | 2013 |
| Influenza pandemic and the duties of healthcare professionals TC Voo, B Capps Singapore Med J 51 (4), 275-281, 2010 | 29 | 2010 |
| Introducing One Health to the Ethical Debate About Zoonotic Diseases in Southeast Asia B Capps, MM Bailey, D Bickford, R Coker, Z Lederman, A Lover, ... Bioethics 29 (8), 588-596, 2015 | 28 | 2015 |
| Falling giants and the rise of gene editing: ethics, private interests and the public good B Capps, R Chadwick, Y Joly, JJ Mulvihill, T Lysaght, H Zwart Human Genomics 11 (1), 20, 2017 | 26 | 2017 |
| Ethical principles for the use of human cellular biotechnologies PR Wolpe, DRDBWGBC Rommelfanger, Karen S Nature biotechnology 35 (11), 1050-1058, 2017 | 24 | 2017 |
| Expect the unexpected: screening for secondary findings in clinical genomics research MP Mackley, B Capps British Medical Bulletin 122 (1), 109-122, 2017 | 22 | 2017 |
| The use of depot naltrexone under legal coercion: the case for caution W Hall, B Capps, A Carter Addiction 103 (12), 1922-1924, 2008 | 21 | 2008 |
| Authoritative regulation and the stem cell debate B Capps Bioethics 22 (1), 43-55, 2008 | 21 | 2008 |
| The Public Interest, Public Goods, and Third-Party Access to UK Biobank B Capps Public Health Ethics 5 (3), 240-251, 2012 | 19 | 2012 |
| Where Does Open Science Lead Us During a Pandemic? A Public Good Argument to Prioritize Rights in the Open Commons B Capps Cambridge Quarterly of Healthcare Ethics 30 (1), 11-24, 2021 | 18 | 2021 |
| Libertarianism, legitimation, and the problems of regulating cognition-enhancing drugs B Capps Neuroethics 4 (2), 119-128, 2011 | 18 | 2011 |
| Do Chimeras Have Minds?: The Ethics of Clinical Research on a Human–Animal Brain Model B Capps Cambridge Quarterly of Healthcare Ethics 26 (4), 577-591, 2017 | 17 | 2017 |
| Can a good tree bring forth evil fruit? The funding of medical research by industry. B Capps British medical bulletin 118 (1), 5-15, 2016 | 16 | 2016 |
